XtalPi Recognized with Multiple Prestigious Awards: Pioneering Innovation Highlights Long-Term Value

XtalPi (XtalPi Holdings, XTALPI, Stock Code:2228.HK) Since its establishment in 2015, XtalPi has continuously strengthened its frontier technology innovation capabilities, focused on source innovation in the biopharmaceutical industry, and further expanded into high-value R&D application scenarios such as new materials, energy chemicals, and agricultural seed industries, achieving practical results in multiple key areas. The company’s development has also reached milestone progress. In June 2024, the company successfully listed on the Hong Kong Stock Exchange and was subsequently included in the MSCI China Index, Hang Seng Composite Index, Hang Seng Biotechnology Index, HKEX Tech 100 Index, Shenzhen-Hong Kong Connect, and Shanghai-Hong Kong Connect lists. XtalPi's long-term value continues to be realized as it enters a new phase of rapid development.

Recently, XtalPi has not only been honored with2025【ESG Pioneer 60】Annual Corporate ESG Practice Award，Has also received numerous honors in both the capital markets and the biopharmaceuticals industry, fromTechnological innovation strength, commercial cooperation results, long-term investment value, and other multi-dimensional aspects,This affirms the efforts and dedication of XtalPi and its team over the past year, and also highlights the high recognition from the capital market, well-known commercial securities media, industry think tank platforms, etc., of XtalPi's leading position in the industry and long-term development potential.

China Securities Journal·2025 Listed Company Golden Bull Award

At the 2025 Listed Companies (H Shares) Golden Bull Awards Ceremony hosted by China Securities Journal, XtalPi won the "Golden Bull Award for Technological Innovation" for the first time. Other recipients of the Golden Bull Award include industry leaders such as CATL, Sinopec, Hengrui Medicine, and Fuyao Glass.

The Golden Bull Award, founded by the China Securities Journal in 1999, has developed into one of the most credible awards in China's capital market. The award has always adhered to “Open, Fair, Just” The principle is to discover listed companies that have demonstrated excellent comprehensive strength and forward-looking layout in institutional innovation and industrial transformation. This year's selection focuses on innovative breakthroughs in cutting-edge technology fields such as artificial intelligence, new energy, and biomedicine. It recognizes benchmark companies that have successfully expanded their business, brand, and technology overseas in a globalized context. It also highlights outstanding examples that emphasize actively fulfilling social responsibilities, valuing shareholder returns, and promoting sustainable development for long-term value while pursuing commercial success.

China Securities Journal·2025 SSE Eagle·Golden Quality Award

Recently, the 2025 Shanghai Securities News (Chaohu) High-Quality Development Conference for Listed Companies and the "SSE Eagle·Golden Quality" Awards Ceremony, guided by the China Association for Public Companies and hosted by the Shanghai Securities News and China Securities Network, successfully concluded. XtalPi was awarded the Sci-Tech Innovation Enterprise Award.

The "SSE Eagle·Golden Quality" Awards, initiated and hosted by the Shanghai Securities News under the Xinhua News Agency, are an authoritative benchmark for measuring the comprehensive strength of listed companies in China's capital market, and are hailed as the "barometer of high-quality development." This selection focuses on market entities that actively contribute to the process of high-quality development, aiming to recognize benchmark enterprises that drive development through innovation and lead change with technology.

Forbes China·2025 Enterprise with Investment Value

Forbes China, a globally renowned business media brand, recently released the results of the "2025 Forbes China Family Office Series Awards," and XtalPi was honored with the "2025 Enterprise of Investment Value" award.

The series of rankings hosted by Forbes are called "Economic Barometer" and “"Wealth Barometer". As a business media brand centered on innovation, Forbes China consistently conducts a series of selection activities focused on themes such as wealth creation, wealth management, wealth ethics, and wealth lifestyle. To spotlight the current state of development of family offices in China and showcase the operational wisdom and achievements of outstanding family offices, Forbes China has once again launched the "2025 Forbes China Family Office Series Selection" following its debut in 2024. Since its launch in June, it has garnered widespread attention. The Forbes China list brings together innovative benchmarks from various fields and serves as an important reference for the global business community and investors to understand investment opportunities and market trends.

Zhitong Finance·2025 Annual

Golden Hong Kong Stock Awards, Best IR Team Award

At the 10th Zhitong Finance Awards Ceremony, XtalPi was honored with the "2025 Golden Hong Kong Stock Award" and "Best IR Team Award" for its outstanding operational performance, sustainable development potential, and exceptional comprehensive strength.

Winners of the "Golden Hong Kong Stock Award" in the same period also included well-known companies from various fields such as Lenovo Group, BeiGene, and CITIC Limited. The "2025 Golden Hong Kong Stock Award" is hailed as one of the most influential selections in the Hong Kong and US stock investment community, consistently focusing on identifying outstanding Hong Kong-listed companies with standardized governance, strong growth potential, the ability to deliver sustained value returns, and a proactive commitment to social responsibility.

WIM Innovators Annual Meeting · 2025

Top 10 Innovative Biomedical Enterprises in China

Recently, the "WIM2025 Innovators Annual Conference," hosted by Yiou and co-organized by multiple authoritative institutions, was held in Beijing. XtalPi successfully made it onto the "Top 10 Innovative Biopharmaceutical Companies in China 2025" list.

The WIM Innovators Annual Meeting is a high-profile event in China that focuses on the forecasting of "future industry" trends and the recognition of benchmark achievements. Its annual rankings, based on rigorous data analysis and professional industry insights, are widely regarded as an authoritative barometer for measuring enterprises' technological innovation capabilities and commercial influence. The "Top 10 Biomedical Innovation Enterprises" list is particularly prominent, aiming to select industry pioneers with genuine technological breakthroughs and high growth potential.